logo

11.88

11.88 (-2.99%)

As of Mar 06, 2024

Iteos Therapeutics, Inc. [ITOS]

Source: 

Company Overview

We are a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for people living with cancer. We leverage our deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the aim of restoring the immune response against cancer. Our innovative pipeline includes two clinical-stage programs targeting novel, de-risked immuno-oncology pathways. Each of our therapies in development has optimized pharmacologic properties designed to improve clinical outcomes.

CountryUS
Headquarterswatertownmassachusetts
Phone Number857-204-4583
Industry
manufacturing
CEOMichel Detheux
Websitewww.clinicaltrials.gov

Related Stories